WeVote
Log In

Bill

Bill

SB 253

AN ACT relating to medicinal cannabis.

2026 Regular Session Introduced by Steve West

Establishes a regulated framework for medical cannabis in Kentucky, enabling qualifying patients to access cannabis products through licensed cultivators, dispensaries, and oversig

to Committee on Committees (S)
#administrativeregulationsandproceedings #agriculture #boardsandcommissions #cannabis #courts #circuit #drugsandmedicines #healthandmedicalservices #stateagencies #vaping
0
WeVote Research Nonpartisan
Bill Summary · SB 253

Summary of SB 253 (Session 2026RS) – Kentucky

Purpose and intent

  • Establishes legislative framework for medicinal cannabis in Kentucky. The bill is framed to regulate medical use of cannabis for qualifying patients and outline the state’s regulatory structure, licensing, and oversight.

Key provisions and changes

  • Medical use authorization

    • Creates a pathway for patients with qualifying medical conditions to legally access cannabis products for medical purposes through state-approved channels.
    • Establishes eligibility criteria and clinical oversight requirements for patients and designated caregivers.

  • Regulatory framework and licensing

    • Creates state regulatory authority or designates an existing agency to oversee licensing of cultivators, processors, testing laboratories, and dispensaries.
    • Specifies licensure issuance, renewal, fees, and compliance requirements, including background checks and security protocols.

  • Product standards and testing

    • Sets quality control standards for medicinal cannabis products (e.g., labeling, potency, contaminants).
    • Requires periodic testing by licensed laboratories and product traceability from cultivation to patient.

  • Dispensing and patient access

    • Outlines how patients can obtain medicinal cannabis (e.g., through registered dispensaries or approved medical service providers).
    • Describes patient registration processes, caregiver roles, and limits on quantities to prevent diversion.
    • Includes provisions for physician or practitioner certification and ongoing treatment oversight.

  • Public health and safety

    • Addresses safety measures, elder and pediatric considerations, driver impairment guidelines, and restrictions on use in certain public or workplace settings.
    • Establishes disciplinary actions and penalties for noncompliance by licensees or registered patients.

  • Rural and economic considerations

    • May include provisions to foster rural access, job creation, and tax implications related to licensing, cultivation, processing, and sales.
    • Potential programs for license application assistance or geographic distribution of licenses.

  • Criminal and regulatory compliance

    • Replaces or modifies existing prohibitions and introduces penalties for illicit cultivation, distribution, or possession outside the medical program.
    • Outlines enforcement mechanisms and interagency cooperation.

  • Taxation and funding

    • Recommends or imposes licensing fees, taxes, or revenue allocations related to the medicinal cannabis program.
    • May specify uses for collected funds (e.g., program administration, public health initiatives).

Who would be affected

  • Patients with qualifying conditions who obtain certification to use medicinal cannabis.
  • Designated caregivers authorized to assist registered patients.
  • Physicians and practitioners who certify patients and oversee treatment.
  • Licensed entities: cultivators, processors, testing laboratories, and dispensaries.
  • Regulatory agencies tasked with overseeing the medical cannabis program.
  • Law enforcement and public health agencies involved in compliance and enforcement.

Procedural and timeline aspects

  • Legislative status: Introduced in the Senate and referred to Committee on Committees (S) on February 25, 2026.
  • Next steps in process: Committee review, potential floor consideration in the Senate, and subsequent action in the House (if passed by Senate) or reconciliations as applicable per Kentucky’s legislative process.
  • Implementation timeline: (Not specified in the summary) Likely includes phased licensing, program launch, and ongoing rulemaking once statutes are enacted; dates would be set in committee hearings and implementing regulations.

If you’d like, I can tailor this summary to emphasize specific sections (e.g., licensing details, patient qualification criteria, or proposed tax structure) once the bill’s full text and fiscal notes are available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.